Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
05/2005
05/19/2005WO2005044312A1 Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
05/19/2005WO2005044310A2 Embolic compositions comprising polymer particle and radiopaque material
05/19/2005WO2005044293A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same
05/19/2005WO2005044224A2 Drug delivery system based on polymer nanoshells
05/19/2005WO2005044100A1 Semipermeable sensors for detecting analyte
05/19/2005WO2005043993A1 Transgenic amphibian models for lymphatic vessel development
05/19/2005WO2005019247A3 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
05/19/2005US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders
05/19/2005US20050107583 Transport peptides for controlled delivery of substances into cells; drug delivery
05/19/2005US20050107471 New esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
05/19/2005US20050107320 Improve phenotypic response and receptive to the therapeutic agent by administering a vector comprising a gene into a mammalian cell, wherein expression of the heterologous protein within the cell; brian neurological disorder, Parkinson's disease; tissue-targeted therapy
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050106635 Identifying agents that alter thyroid hormone metabolism or cholesterol and lipid metabolism via coxsackie and adenovirus receptor (CAR) for use as tools in treatment of obesity, cholesterolemia and dyslipidemia
05/19/2005US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders
05/19/2005US20050106586 Detection of neurodegenerative diseases
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106119 Inherently radiopaque polymeric products for embolotherapy
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/19/2005US20050106107 TRansdermal drug delivery device; topical applying mycobacterial antigen; diagnosis of tuberculosis
05/19/2005US20050106106 In-vivo diagnostic method by near infrared radiation
05/19/2005US20050106105 Complex of annexin and ultrasonic contrast particles or polymer
05/19/2005US20050106104 Detection using reference profile; calibration of metalbolites
05/19/2005US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/19/2005US20050106101 Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
05/19/2005US20050106100 Diagnosis, detection, monitoring a pathology condition; chelate compound labeled with metalloproteinase; cardiovascular disorders; anticancer agents; antitumor agents; antiischemic agents
05/19/2005DE10348319A1 Bindemoleküle für die Extra-Domäne B von Fibronectin zur Detektion von atherosklerotischen Plaques Binding molecules for the extra-domain B of fibronectin for detection of atherosclerotic plaques
05/19/2005CA2543030A1 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina)
05/19/2005CA2542527A1 Rna interferance mediated inhibition of cholinergic muscarinic receptor (chrm3) gene expression using short interfering nucleic acid /sina)
05/19/2005CA2539885A1 Semipermeable sensors for detecting analyte
05/18/2005EP1530465A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound
05/18/2005EP1530456A2 Non-vesicular cationic lipid formulations
05/18/2005EP1066402B1 Methods of screening agents for activity using teleosts
05/18/2005CN1617935A Microorganisms and cells for diagnosis and therapy of tumors
05/18/2005CN1617694A Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
05/18/2005CN1617668A Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
05/18/2005CN1616111A Diagnostic imaging contrast agents with extended blood retention
05/18/2005CN1201738C Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
05/17/2005US6894151 Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use
05/17/2005CA2098915C Echo contrast agent
05/12/2005WO2005043159A1 Water-soluble compound
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042461A1 Compound with amyloid affinity
05/12/2005WO2005042034A1 Peptides whose uptake by cells is controllable
05/12/2005WO2005042033A1 Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use
05/12/2005WO2005042005A1 Amino acid composition with increased blood brain barrier permeability
05/12/2005WO2005041883A2 Reduction of unintended use of transdermal devices
05/12/2005WO2005041882A2 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
05/12/2005WO2005041860A2 Stem cells for use in locating and targeting tumor cells
05/12/2005WO2005041756A2 Skin test for detecting non-allergic hypersensitivity
05/12/2005US20050102708 Rodent model generated by continuous infusion of a Fe2+, A beta 42 and buthionine sulfoximine for use as diagnostic and therapeutic screening tool in detection and treatment of alzheimer's disease
05/12/2005US20050101775 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
05/12/2005US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents
05/12/2005US20050101522 Antihyperplastic agents; antitumor agents; side effect reduction
05/12/2005US20050100963 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response
05/12/2005US20050100542 Cytotoxicity mediation of cells evidencing surface expression of CD44
05/12/2005US20050100510 Methods for using gadolinium as a contrast media
05/12/2005CA2544255A1 Water-soluble compound
05/12/2005CA2543919A1 Peptides whose uptake by cells is controllable
05/12/2005CA2543296A1 Reconstitutable microsphere compositions useful as ultrasonic contrast agents
05/12/2005CA2543292A1 Reduction of unintended use of transdermal devices
05/12/2005CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same
05/11/2005EP1529537A1 Bifunctional tridentate pyrazolyl containing ligands for RE, TC and MN tricarbonyl complexes
05/11/2005EP1434571B1 Particle immobilized coatings and uses thereof
05/11/2005EP1068224B1 Pharmaceuticals for the imaging of angiogenic disorders
05/11/2005EP0927049B1 Labelled elastase inhibitors
05/11/2005EP0625200B1 Biosynthetic binding protein for cancer marker
05/11/2005CN1615157A Compositions inhibiting rejection in organ transplantation and method of using the same
05/11/2005CN1613504A Method and use of closed hydrophilic and lipophilic liquid-phase hollow capsules with cores
05/10/2005US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas
05/10/2005US6890311 Methods for performing medical procedures within a breast duct
05/10/2005US6890305 Conversion of carbon 13 labeled sodium bicarbonate to exhaled carbon dioxide is measured to evaluate lung function
05/10/2005CA2132708C Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding
05/06/2005WO2005040416A1 Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease
05/06/2005WO2005040209A1 Human chemokine hcc-1 polypeptides to improve stem cell transplantation
05/06/2005WO2005039750A1 Novel microparticles for ultrasound contrast imaging and drug delivery
05/06/2005WO2005039666A1 Ultrasound coating for enhancing visualization of medical devices in ultrasound images
05/06/2005WO2005039646A1 Imaging agent for magnetic resonance tissue perfusion imaging method and apparatus
05/06/2005WO2005039495A2 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
05/06/2005WO2005039446A1 Post-biopsy cavity treatment implants and methods
05/06/2005WO2005025528A8 Dye composition and method for detection of demineralized lesions in teeth
05/06/2005WO2005004592A3 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
05/06/2005WO2004112839A3 Specific high-relaxivity conjugate compounds for magnetic resonance imaging
05/06/2005WO2004103183A3 Ultrasound coupling medium for use in medical diagnostics
05/06/2005CA2541138A1 Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease
05/06/2005CA2541107A1 Post-biopsy cavity treatment implants and methods
05/05/2005US20050096254 Peptide deformylase activated prodrugs
05/05/2005US20050095695 Nanofibrillar structure and applications including cell and tissue culture
05/05/2005US20050095653 Ocular diagnosis of alzheimer's disease
05/05/2005US20050095428 Blocking blood vessel to tumor; drug delivery
05/05/2005US20050095298 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis
05/05/2005US20050095229 Comprises conduit connected to blood pool, cell culture for producing analyte (insulin, glucagons, and/or somatostatin), and concentration controller (integrated circuit)
05/05/2005US20050095201 Protein or peptide containing asparagyl-4-aminobutane and/or glutamyl-4-aminobutane residues; diagnostic magnetic resonance imaging
05/05/2005US20050095200 Enhancing video capsule in vivo gastrointestinal system diagnosis
05/05/2005US20050095174 Semipermeable sensors for detecting analyte
05/04/2005EP1526873A1 Conjugated lysine copolymers for drug delivery and imaging
05/04/2005EP1305029A4 Method of increasing sensitivity of mammography
05/04/2005EP1259532B1 Bile acids conjugates with metal ion chelates and the use thereof
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 354